SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001347178-20-000010
Filing Date
2020-04-22
Accepted
2020-04-22 16:06:55
Documents
4
Effectiveness Date
2020-04-22

Document Format Files

Seq Description Document Type Size
1 DEFA14A defa14a.htm DEFA14A 33970
2 vandanoticeproxy2020page1.jpg GRAPHIC 144785
3 vandanoticeproxy2020page2.jpg GRAPHIC 252533
4 vandanoticeproxy2020page3.jpg GRAPHIC 97259
  Complete submission text file 0001347178-20-000010.txt   716587
Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Filer) CIK: 0001347178 (see all company filings)

IRS No.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-34186 | Film No.: 20808031
SIC: 2834 Pharmaceutical Preparations